Patients with recurrent gynecologic cancers and Wnt activating mutations demonstrated greater clinical benefit when treated with DKN-01 therapy

Arend, R; Castro, C; Matulonis, U; Hamilton, E; Gunderson, C; Lybarger, K; Goodman, H; Duska, L; Mahdi, H; ElNaggar, A; Kagey, M; Barroilhet, L; Bradley, W; Sachdev, J; Sirard, C; O'Malley, D; Birrer, M

GYNECOLOGIC ONCOLOGY, 2021; 162 (): S16